Objectives: To investigate the tolerability and efficacy of moxonidine in the treatment of arterial hypertension in patients with obstructive pulmonary disease. The ACE inhibitor ramipril was used ...

At the conclusion of the washout phase, eligible patients were randomised using the software program Rando 4.0, as provided by Solvay Pharmaceuticals (Germany), to either moxonidine (0.2mg once ...